Pulmonx Corp Valuation
| LUNG Stock | USD 6.26 0.14 2.19% |
At this time, the company appears to be undervalued. Pulmonx Corp holds a recent Real Value of $7.4 per share. The prevailing price of the company is $6.26. Our model determines the value of Pulmonx Corp from analyzing the company fundamentals such as Return On Equity of -0.52, operating margin of (0.69) %, and Shares Outstanding of 39.49 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Pulmonx Corp's valuation include:
Price Book 2.8252 | Enterprise Value | Enterprise Value Ebitda (5.62) | Price Sales 3.1868 | Forward PE 28.3286 |
Undervalued
Today
Please note that Pulmonx Corp's price fluctuation is slightly risky at this time. Calculation of the real value of Pulmonx Corp is based on 3 months time horizon. Increasing Pulmonx Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pulmonx stock is determined by what a typical buyer is willing to pay for full or partial control of Pulmonx Corp. Since Pulmonx Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pulmonx Stock. However, Pulmonx Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.26 | Real 7.4 | Target 11.58 | Hype 6.26 |
The real value of Pulmonx Stock, also known as its intrinsic value, is the underlying worth of Pulmonx Corp Company, which is reflected in its stock price. It is based on Pulmonx Corp's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Pulmonx Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Pulmonx Corp helps investors to forecast how Pulmonx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pulmonx Corp more accurately as focusing exclusively on Pulmonx Corp's fundamentals will not take into account other important factors: When choosing an evaluation method for Pulmonx Corp, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Pulmonx Corp Cash |
|
Pulmonx Valuation Trend
Comparing Pulmonx Corp's enterprise value against its market capitalization is a good way to estimate the value of Pulmonx Corp uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Pulmonx Corp Total Value Analysis
Pulmonx Corp is now estimated to have valuation of 213.39 M with market capitalization of 252.72 M, debt of 41.42 M, and cash on hands of 162.09 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Pulmonx Corp fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
213.39 M | 252.72 M | 41.42 M | 162.09 M |
Pulmonx Corp Investor Information
About 93.0% of the company shares are owned by institutional investors. The book value of Pulmonx Corp was now reported as 2.38. The company recorded a loss per share of 1.47. Pulmonx Corp had not issued any dividends in recent years. Based on the analysis of Pulmonx Corp's profitability, liquidity, and operating efficiency, Pulmonx Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Pulmonx Corp Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Pulmonx Corp has an asset utilization ratio of 38.63 percent. This implies that the Company is making $0.39 for each dollar of assets. An increasing asset utilization means that Pulmonx Corp is more efficient with each dollar of assets it utilizes for everyday operations.Pulmonx Corp Ownership Allocation
Pulmonx Corp owns a total of 39.49 Million outstanding shares. The majority of Pulmonx Corp outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pulmonx Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pulmonx Corp. Please pay attention to any change in the institutional holdings of Pulmonx Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Pulmonx Corp Profitability Analysis
The company reported the previous year's revenue of 68.67 M. Net Loss for the year was (60.84 M) with profit before overhead, payroll, taxes, and interest of 58.81 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Pulmonx Corp's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Pulmonx Corp and how it compares across the competition.
About Pulmonx Corp Valuation
The stock valuation mechanism determines Pulmonx Corp's current worth on a weekly basis. Our valuation model uses a comparative analysis of Pulmonx Corp. We calculate exposure to Pulmonx Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pulmonx Corp's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 58.4 M | 61.3 M | |
| Pretax Profit Margin | (1.01) | (1.06) | |
| Operating Profit Margin | (1.04) | (1.09) | |
| Net Loss | (1.02) | (1.07) | |
| Gross Profit Margin | 0.67 | 0.55 |
Pulmonx Corp Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pulmonx Corp does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 38 M | |
| Forward Price Earnings | 28.3286 |
Pulmonx Corp Current Valuation Indicators
Valuation refers to the process of determining the present value of Pulmonx Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Pulmonx we look at many different elements of the entity such as Pulmonx's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Pulmonx Corp, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Pulmonx Corp's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Pulmonx Corp's worth.Complementary Tools for Pulmonx Stock analysis
When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |